Timothée Dub - Epidemiology

Author Information

Timothée Dub is affiliated with the National Institute for Health and Welfare in Helsinki, Finland, and the European Programme for Intervention Epidemiology Training (EPIET) at the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden. His research primarily focuses on epidemiology, with a significant emphasis on infectious diseases, including COVID-19 and tularaemia.

Research Contributions

Timothée Dub has made substantial contributions to the field of epidemiology through numerous publications. His recent research includes studies on primary care surveillance for tularaemia, population-based seroprevalence of SARS-CoV-2 in Europe, and the impact of COVID-19-related stigma in Finland. He has also investigated the detection methods for SARS-CoV-2 infection and the dynamics of household transmission of the virus. Furthermore, his work has examined COVID-19 vaccine acceptance and the analytical evaluation of antibody tests for serosurveillance.

Aliases

Timothée Dub is also known by the following aliases: T Dub, T. Dub, and Timothee Dub.

Publication and Citation Metrics

Metric	Value
Citation Count	3313
H-index	15
Paper Count	44

Publications:

Is clinical primary care surveillance for tularaemia a useful addition to laboratory surveillance? An analysis of notification data for Finland, 2013 to 2019

DOI: 10.2807/1560-7917.ES.2022.27.4.2100098

Year: 2022

SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review

DOI: 10.1136/bmjopen-2020-045425

Year: 2021

Learning about COVID-19-related stigma, quarantine and isolation experiences in Finland

DOI: 10.1371/journal.pone.0247962

Year: 2021

Detection of SARS-CoV-2 Infection in Gargle, Spit, and Sputum Specimens

DOI: 10.1128/Spectrum.00035-21

Year: 2021

COVID-19 outbreak at a reception centre for asylum seekers in Espoo, Finland

DOI: 10.1016/j.jmh.2021.100043

Year: 2021

High Secondary Attack Rate and Persistence of SARS-CoV-2 Antibodies in Household Transmission Study Participants, Finland 2020

DOI: 10.2139/ssrn.3892117

Year: 2021

High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020

DOI: 10.1017/S0950268821001114

Year: 2021

Analytical and clinical evaluation of antibody tests for SARS-CoV-2 serosurveillance studies used in Finland in 2020

DOI: 10.1101/2021.01.21.21250207

Year: 2021

High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020

DOI: 10.1101/2021.07.25.21260925

Year: 2021

Detection of SARS-CoV-2 infection in gargle, spit and sputum specimens

DOI: 10.1101/2021.05.02.21255857

Year: 2021

Who Are the Key Stakeholders in Real-Time Collaboration?

What are some real-world examples of the Jaccard Index in Epidemiology?

What are the Challenges in Studying Dermal Exposure?

Why Are Serogroups Important in Epidemiology?

What Tools and Techniques Do They Use?

What Challenges Do Internal Auditors Face in Epidemiology?

How is Solvent Exposure Measured?

How Can Spatial Analysis Improve Public Health Interventions?

What is Primary Vaccine Failure?

Why Are Latrines Important in Epidemiology?

Partnered Content Networks

Relevant Topics